Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 18,790,000 | 18,380,000 | 17,444,000 | 15,638,000 | 14,214,200 |
| Cost of Goods | 4,581,000 | 4,508,000 | 4,639,000 | 4,293,000 | 4,056,390 |
| Gross Profit | 14,209,000 | 13,872,000 | 12,805,000 | 11,345,000 | 10,157,810 |
| Operating Expenses | 8,545,000 | 8,055,000 | 9,185,000 | 6,628,000 | 5,226,402 |
| Operating Income | 5,664,000 | 5,817,000 | 3,620,000 | 4,717,000 | 4,931,794 |
| Interest Expense | 278,000 | 84,000 | -20,000 | -28,000 | 0 |
| Other Income | -54,000 | -8,000 | 28,000 | 91,000 | 1,018,523 |
| Pre-tax Income | 5,332,000 | 5,725,000 | 3,668,000 | 4,836,000 | 5,950,317 |
| Income Tax | 1,204,000 | 450,000 | 235,000 | 658,000 | 1,313,802 |
| Net Income Continuous | 4,128,000 | 5,275,000 | 3,433,000 | 4,178,000 | 4,636,515 |
| Net Income | $4,128,000 | $5,275,000 | $3,433,000 | $4,178,000 | $4,636,515 |
| EPS Basic Total Ops | 2.58 | 3.35 | 2.18 | 2.65 | N/A |
| EPS Basic Continuous Ops | 2.60 | 3.35 | 2.18 | 2.65 | N/A |
| EPS Diluted Total Ops | 2.56 | 3.35 | 2.18 | 2.65 | N/A |
| EPS Diluted Continuous Ops | 2.57 | 3.35 | 2.18 | 2.65 | N/A |
| EBITDA(a) | $6,561,000 | $6,967,000 | $4,892,000 | $5,901,000 | $5,629,286 |